1. Abecasis, A. B., K. Deforche, L. T. Bacheler, P. McKenna, A. P. Carvalho, P. Gomes, A. M. Vandamme, and R. J. Camacho. 2006. Investigation of baseline susceptibility to protease inhibitors in HIV-1 subtypes C, F, G and CRF02_AG. Antivir. Ther.11:581-589.
2. The Role of Antibody Polyspecificity and Lipid Reactivity in Binding of Broadly Neutralizing Anti-HIV-1 Envelope Human Monoclonal Antibodies 2F5 and 4E10 to Glycoprotein 41 Membrane Proximal Envelope Epitopes
3. Alexander, C. S., V. Montessori, B. Wynhoven, W. Dong, K. Chan, M. V. O'Shaughnessy, T. Mo, M. Piaseczny, J. S. Montaner, and P. R. Harrigan. 2002. Prevalence and response to antiretroviral therapy of non-B subtypes of HIV in antiretroviral-naive individuals in British Columbia. Antivir. Ther.7:31-35.
4. Selection, Transmission, and Reversion of an Antigen-Processing Cytotoxic T-Lymphocyte Escape Mutation in Human Immunodeficiency Virus Type 1 Infection
5. Avila, M. M., M. A. Pando, G. Carrion, L. M. Peralta, H. Salomon, M. G. Carrillo, J. Sanchez, S. Maulen, J. Hierholzer, M. Marinello, M. Negrete, K. L. Russell, and J. K. Carr. 2002. Two HIV-1 epidemics in Argentina: different genetic subtypes associated with different risk groups. J. Acquir. Immune Defic. Syndr.29:422-426.